Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur

doi:10.1083/jcb.110.6.2195

This Article

Full Text (PDF, 15487K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JCB

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Joyce, M. E.

Articles by Bolander, M. E.

Search for Related Content

PubMed

PubMed Citation

Articles by Joyce, M. E.

Articles by Bolander, M. E.

Pubmed/NCBI databases

Substance via MeSH

Social Bookmarking

What's this?

ARTICLES

Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur

ME Joyce, AB Roberts, MB Sporn and ME Bolander
Orthopaedic Research Unit, National Institute of Arthritis Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, Maryland 20892.

We have investigated the ability of exogenous transforming growth factor-beta (TGF-beta) to induce osteogenesis and chondrogenesis, critical events in both bone formation and fracture healing. Daily injections of TGF-beta 1 or 2 into the subperiosteal region of newborn rat femurs resulted in localized intramembranous bone formation and chondrogenesis. After cessation of the injections, endochondral ossification occurred, resulting in replacement of cartilage with bone. Gene expression of type II collagen and immunolocalization of types I and II collagen were detected within the TGF-beta-induced cartilage and bone. Moreover, injection of TGF-beta 2 stimulated synthesis of TGF- beta 1 in chondrocytes and osteoblasts within the newly induced bone and cartilage, suggesting positive autoregulation of TGF-beta. TGF-beta 2 was more active in vivo than TGF-beta 1, stimulating formation of a mass that was on the average 375% larger at a comparable dose (p less than 0.001). With either TGF-beta isoform, the dose of the growth factor determined which type of tissue formed, so that the ratio of cartilage formation to intramembranous bone formation decreased as the dose was lowered. For TGF-beta 1, reducing the daily dose from 200 to 20 ng decreased the cartilage/intramembranous bone formation ratio from 3.57 to zero (p less than 0.001). With TGF-beta 2, the same dose change decreased the ratio from 3.71 to 0.28 (p less than 0.001). These data demonstrate that mesenchymal precursor cells in the periosteum are stimulated by TGF-beta to proliferate and differentiate, as occurs in embryologic bone formation and early fracture healing.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Xue, W., Comes, N., Borras, T. (2007). Presence of an Established Calcification Marker in Trabecular Meshwork Tissue of Glaucoma Donors. IOVS 48: 3184-3194 [Abstract] [Full Text]
Miller, B. S, Bronk, J. T, Nishiyama, T., Yamagiwa, H., Srivastava, A., Bolander, M. E, Conover, C. A (2007). Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice. J Endocrinol 192: 505-513 [Abstract] [Full Text]
Francois, R J, Neure, L, Sieper, J, Braun, J (2006). Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor {alpha} in two patients with early disease and transforming growth factor {beta} in three more advanced cases. Ann Rheum Dis 65: 713-720 [Abstract] [Full Text]
Quinlan, J. F., Watson, R. W. G., Kelly, G., Kelly, P. M., O'Byrne, J. M., Fitzpatrick, J. M. (2006). Transforming growth factor-beta (TGF-{beta}) in acute injuries of the spinal cord. J Bone Joint Surg Br 88-B: 406-410 [Abstract] [Full Text]
Stevens, M. M., Marini, R. P., Schaefer, D., Aronson, J., Langer, R., Shastri, V. P. (2005). In vivo engineering of organs: The bone bioreactor. Proc. Natl. Acad. Sci. USA 102: 11450-11455 [Abstract] [Full Text]
Grotendorst, G. R., Duncan, M. R. (2005). Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 19: 729-738 [Abstract] [Full Text]
Iu, M.-F., Kaji, H., Sowa, H., Naito, J., Sugimoto, T., Chihara, K. (2005). Dexamethasone suppresses Smad3 pathway in osteoblastic cells. J Endocrinol 185: 131-138 [Abstract] [Full Text]
Pacheco, R. J, Bradbury, M. D, Kasis, A. G, Saleh, M. (2004). Review Management of nonunion in trauma. Trauma 6: 225-247 [Abstract]
GROTENDORST, G. R., RAHMANIE, H., DUNCAN, M. R. (2004). Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J. 18: 469-479 [Abstract] [Full Text]
Sowa, H., Kaji, H., Iu, M. F., Tsukamoto, T., Sugimoto, T., Chihara, K. (2003). Parathyroid Hormone-Smad3 Axis Exerts Anti-apoptotic Action and Augments Anabolic Action of Transforming Growth Factor {beta} in Osteoblasts. J. Biol. Chem. 278: 52240-52252 [Abstract] [Full Text]
Chagraoui, H., Komura, E., Tulliez, M., Giraudier, S., Vainchenker, W., Wendling, F. (2002). Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood 100: 3495-3503 [Abstract] [Full Text]
Sowa, H., Kaji, H., Yamaguchi, T., Sugimoto, T., Chihara, K. (2002). Activations of ERK1/2 and JNK by Transforming Growth Factor beta Negatively Regulate Smad3-induced Alkaline Phosphatase Activity and Mineralization in Mouse Osteoblastic Cells. J. Biol. Chem. 277: 36024-36031 [Abstract] [Full Text]
Scharstuhl, A., Glansbeek, H. L., van Beuningen, H. M., Vitters, E. L., van der Kraan, P. M., van den Berg, W. B. (2002). Inhibition of Endogenous TGF-{beta} During Experimental Osteoarthritis Prevents Osteophyte Formation and Impairs Cartilage Repair. J. Immunol. 169: 507-514 [Abstract] [Full Text]
Szweras, M., Liu, D., Partridge, E. A., Pawling, J., Sukhu, B., Clokie, C., Jahnen-Dechent, W., Tenenbaum, H. C., Swallow, C. J., Grynpas, M. D., Dennis, J. W. (2002). alpha 2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-beta /Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling. J. Biol. Chem. 277: 19991-19997 [Abstract] [Full Text]
Karsdal, M. A., Fjording, M. S., Foged, N. T., Delaisse, J.-M., Lochter, A. (2001). Transforming Growth Factor-beta -induced Osteoblast Elongation Regulates Osteoclastic Bone Resorption through a p38 Mitogen-activated Protein Kinase- and Matrix Metalloproteinase-dependent Pathway. J. Biol. Chem. 276: 39350-39358 [Abstract] [Full Text]
Yang, X., Chen, L., Xu, X., Li, C., Huang, C., Deng, C.-X. (2001). TGF-{beta}/Smad3 Signals Repress Chondrocyte Hypertrophic Differentiation and Are Required for Maintaining Articular Cartilage. JCB 153: 35-46 [Abstract] [Full Text]
Lu, L., Yaszemski, M. J., Mikos, A. G. (2001). TGF-{beta}1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function. JBJS 83: S82-92 [Abstract] [Full Text]
Friedlaender, G. E., Perry, C. R., Cole, J. D., Cook, S. D., Cierny, G., Muschler, G. F., Zych, G. A., Calhoun, J. H., LaForte, A. J., Yin, S. (2001). Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions : A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft. JBJS 83: S151-151 [Abstract] [Full Text]
Lu, L., Yaszemski, M. J., Mikos, A. G. (2001). TGF-{beta}1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function. JBJS 83: S82-S92 [Abstract] [Full Text]
Friedlaender, G. E., Perry, C. R., Cole, J. D., Cook, S. D., Cierny, G., Muschler, G. F., Zych, G. A., Calhoun, J. H., LaForte, A. J., Yin, S. (2001). Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions : A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft. JBJS 83: S151-S151 [Abstract] [Full Text]
Wicke, C., Halliday, B., Allen, D., Roche, N. S., Scheuenstuhl, H., Spencer, M. M., Roberts, A. B., Hunt, T. K. (2000). Effects of Steroids and Retinoids on Wound Healing. Arch Surg 135: 1265-1270 [Abstract] [Full Text]
Fuller, K, Lean, J., Bayley, K., Wani, M., Chambers, T. (2000). A role for TGFbeta(1) in osteoclast differentiation and survival. J. Cell Sci. 113: 2445-2453 [Abstract]
Ranger, A. M., Gerstenfeld, L. C., Wang, J., Kon, T., Bae, H., Gravallese, E. M., Glimcher, M. J., Glimcher, L. H. (2000). The Nuclear Factor of Activated T Cells (Nfat) Transcription Factor Nfatp (Nfatc2) Is a Repressor of Chondrogenesis. JEM 191: 9-22 [Abstract] [Full Text]
HECKMAN, J. D., EHLER, W., BROOKS, B. P., AUFDEMORTE, T. B., LOHMANN, C. H., MORGAN, T., BOYAN, B. D. (1999). Bone Morphogenetic Protein But Not Transforming Growth Factor-{beta} Enchances Bone Formation in Canine Diaphyseal Nonunions Implanted with a Biodegradable Composite Polymer*{{dagger}}. JBJS 81: 1717-29 [Abstract] [Full Text]
Kamakura, S., Sasano, Y., Homma, H., Suzuki, O., Kagayama, M., Motegi, K. (1999). Implantation of Octacalcium Phosphate (OCP) in Rat Skull Defects Enhances Bone Repair. JDR 78: 1682-1687 [Abstract]
Takai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., Yamada, Y. (1998). Transforming Growth Factor-beta Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells. J. Biol. Chem. 273: 27091-27096 [Abstract] [Full Text]
Erlebacher, A., Filvaroff, E. H., Ye, J.-Q., Derynck, R. (1998). Osteoblastic Responses to TGF-beta during Bone Remodeling. Mol. Biol. Cell 9: 1903-1918 [Abstract] [Full Text]
Schulick, A. H., Taylor, A. J., Zuo, W., Qiu, C.-b., Dong, G., Woodward, R. N., Agah, R., Roberts, A. B., Virmani, R., Dichek, D. A. (1998). Overexpression of transforming growth factor beta 1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc. Natl. Acad. Sci. USA 95: 6983-6988 [Abstract] [Full Text]
Gill, R. K., Turner, R. T., Wronski, T. J., Bell, N. H. (1998). Orchiectomy Markedly Reduces the Concentration of the Three Isoforms of Transforming Growth Factor {beta} in Rat Bone, and Reduction Is Prevented by Testosterone. Endocrinology 139: 546-550 [Abstract] [Full Text]
Murakami, S., Nifuji, A., Noda, M. (1997). Expression of Indian Hedgehog in Osteoblasts and Its Posttranscriptional Regulation by Transforming Growth Factor-{beta}. Endocrinology 138: 1972-1978 [Abstract] [Full Text]
JÜRGENSEN, K., AESCHLIMANN, D., CAVIN, V., GENGE, M., HUNZIKER, E. B. (1997). A New Biological Glue for Cartilage-Cartilage Interfaces: Tissue Transglutaminase. JBJS 79: 185-93 [Abstract] [Full Text]
TRIPPEL, S. B., COUTTS, R. D., EINHORN, T. A., MUNDY, G. R., ROSENFELD, R. G. (1996). Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*{{dagger}}. JBJS 78: 1272-86 [Full Text]
Riikonen, T., Koivisto, L., Vihinen, P., Heino, J. (1995). Transforming Growth Factor-beta Regulates Collagen Gel Contraction by Increasing alpha2beta1 Integrin Expression in Osteogenic Cells. J. Biol. Chem. 270: 376-382 [Abstract] [Full Text]
Critchlow, M., Bland, Y., Ashhurst, D. (1994). The effects of age on the response of rabbit periosteal osteoprogenitor cells to exogenous transforming growth factor-beta 2. J. Cell Sci. 107: 499-516 [Abstract]
Boyan, B. D., Schwartz, Z., Swain, L. D. (1992). In Vitro Studies on the Regulation of Endochondral Ossification by Vitamin D. CROBM 3: 15-30 [Full Text]
Rathjen, P D, Nichols, J, Toth, S, Edwards, D R, Heath, J K, Smith, A G (1990). Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations.. Genes Dev. 4: 2308-2318 [Abstract]
Lai, C.-F., Feng, X., Nishimura, R., Teitelbaum, S. L., Avioli, L. V., Ross, F. P., Cheng, S.-L. (2000). Transforming Growth Factor-beta Up-regulates the beta 5 Integrin Subunit Expression via Sp1 and Smad Signaling. J. Biol. Chem. 275: 36400-36406 [Abstract] [Full Text]